Disease
|
Drug/Important Bio-Agent (IBA)
5 | AQ4NIBA
06/2007
-
04/2000 |
3 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2006
-
03/2002 |
2 | EnzymesIBA
09/2004
-
03/2002 |
1 | polysialic acidIBA
10/2012 |
1 | Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
10/2012 |
1 | Proteins (Proteins, Gene)FDA Link
05/2012 |
1 | ProteomeIBA
05/2012 |
1 | TrypsinIBA
05/2012 |
1 | IntegrinsIBA
06/2009 |
1 | Cytochrome P-450 CYP2B6 (CYP2B6)IBA
06/2006 |
1 | Cytotoxins (Cytolysins)IBA
06/2006 |
1 | Cytochrome P-450 CYP3AIBA
06/2006 |
1 | Cytochrome P-450 CYP1A1 (CYP1A1)IBA
06/2006 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2005 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2005 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
01/2005 |
1 | ChromatinIBA
01/2005 |
1 | Antineoplastic Agents (Antineoplastics)IBA
03/2002 |
1 | ResveratrolIBA
03/2002 |
1 | 3,3',4,5'-tetrahydroxystilbeneIBA
03/2002 |
1 | CytochromesIBA
01/2002 |
1 | ProdrugsIBA
06/2000 |
1 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2000 |
1 | Annexin A5IBA
03/2000 |
1 | Etoposide (VP 16)FDA LinkGeneric
03/2000 |
|
Therapy/Procedure
|